“RIVAROXABAN: AN ORAL DIRECT INHIBITOR OF FACTOR X-A”. International Research Journal of Pharmacy, vol. 2, no. 8, Nov. 2024, pp. 1-5, https://irjponline.org/index.php/irjp/article/view/1833.